CA2342072A1 - Kunitz domain polypeptide zkun6 - Google Patents

Kunitz domain polypeptide zkun6 Download PDF

Info

Publication number
CA2342072A1
CA2342072A1 CA002342072A CA2342072A CA2342072A1 CA 2342072 A1 CA2342072 A1 CA 2342072A1 CA 002342072 A CA002342072 A CA 002342072A CA 2342072 A CA2342072 A CA 2342072A CA 2342072 A1 CA2342072 A1 CA 2342072A1
Authority
CA
Canada
Prior art keywords
kunitz domain
zkun6
domain polypeptide
proteinase inhibitors
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002342072A
Other languages
French (fr)
Other versions
CA2342072C (en
Inventor
Darrell C. Conklin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics, Inc.
Darrell C. Conklin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics, Inc., Darrell C. Conklin filed Critical Zymogenetics, Inc.
Publication of CA2342072A1 publication Critical patent/CA2342072A1/en
Application granted granted Critical
Publication of CA2342072C publication Critical patent/CA2342072C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Proteinase inhibitors comprising a Kunitz domain are disclosed. The Kunitz domain comprises a sequence of amino acid residues as shown in SEQ ID NO:3, wherein the sequence is at least 80 % identical to residues 6 through 56 of SEQ ID NO:2. Also disclosed are methods for making the proteinase inhibitors and expression vectors and cultured cells that are useful within the methods. The proteinase inhibitors may be used as components of cell culture media, in protein purification, and in certain therapeutic and diagnostic applications.
CA002342072A 1998-09-03 1999-09-01 Kunitz domain polypeptide zkun6 Expired - Fee Related CA2342072C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14809298A 1998-09-03 1998-09-03
US09/148,092 1998-09-03
PCT/US1999/020202 WO2000014235A1 (en) 1998-09-03 1999-09-01 Kunitz domain polypeptide zkun6

Publications (2)

Publication Number Publication Date
CA2342072A1 true CA2342072A1 (en) 2000-03-16
CA2342072C CA2342072C (en) 2005-01-11

Family

ID=22524234

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002342072A Expired - Fee Related CA2342072C (en) 1998-09-03 1999-09-01 Kunitz domain polypeptide zkun6

Country Status (6)

Country Link
EP (1) EP1108029A1 (en)
JP (1) JP2002524076A (en)
AU (1) AU5805499A (en)
CA (1) CA2342072C (en)
IL (1) IL141644A0 (en)
WO (1) WO2000014235A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
PT2311432E (en) 2002-06-07 2015-02-09 Dyax Corp Modified kunitz domain polypeptides and their use for reducing ischemia or the onset of a systemic inflammatory response associated with a surgical procedure
AU2012216529B2 (en) * 2002-08-28 2014-12-11 Takeda Pharmaceutical Company Limited Methods for preserving organs and tissues
DK1542710T3 (en) * 2002-08-28 2012-10-15 Dyax Corp Method of preserving organs and tissues
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
JPWO2009101737A1 (en) * 2008-02-14 2011-06-02 国立大学法人大阪大学 Protein expression vector with peptide tag containing methionine residue
AU2010203712A1 (en) 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
LT2521568T (en) 2010-01-06 2018-12-10 Dyax Corp. Plasma kallikrein binding proteins
CN105713092B (en) 2011-01-06 2019-09-10 戴埃克斯有限公司 Blood plasma prekallikrein binding protein
AU2016366557B2 (en) 2015-12-11 2024-01-25 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE529444T1 (en) * 1994-01-11 2011-11-15 Dyax Corp HUMAN PLASMIN INHIBITORS DERIVED FROM THE KUNITZ DOMAINS

Also Published As

Publication number Publication date
EP1108029A1 (en) 2001-06-20
IL141644A0 (en) 2002-03-10
AU5805499A (en) 2000-03-27
JP2002524076A (en) 2002-08-06
WO2000014235A1 (en) 2000-03-16
CA2342072C (en) 2005-01-11

Similar Documents

Publication Publication Date Title
CA2263889A1 (en) P-selectin ligand proteins
EP0994190A3 (en) DNA conferring L-homoserine resistance to bacteria, and its use
WO1998051799A1 (en) Novel differentiation inhibitor
BG102554A (en) Vectors and methods for gene transfer into cells
DE69133587D1 (en) Recombinant DNA sequences encoding enzymes free of feedback inhibition, plasmids containing these sequences, transformed microorganisms useful for production of aromatic amino acids, and their methods of preparation by fermentation
CA2079229A1 (en) Ubiquitin-Specific Protease
CA2342072A1 (en) Kunitz domain polypeptide zkun6
WO2000034474A3 (en) Growth factor homolog zvegf3
ATE282705T1 (en) IMPROVED BARSTAR GENE
EP1137808A4 (en) Methods for making recombinant cells
Stepanov et al. Intracellular serine protease from Bacillus subtilis. Structural comparison with extracellular serine proteases-subtilisins
CA2260365A1 (en) Differentiation-suppressive polypeptide
Kim et al. Molecular cloning and nucleotide sequence of Streptomyces griseus trypsin gene
NZ506748A (en) Nucleic acids encoding a GFR alpha 3 polypeptide; host cell and vectors for production of the GRF alpha 3 protein and an assay for detecting GRFalpha 3 production
WO2002030958A3 (en) Casein peptide fragments with growth-influencing activity on cell cultures
WO2001064888A3 (en) Kunitz domain polypeptide zkun8
DE69633676D1 (en) ALKALINE PROTEASE, METHOD FOR THE PRODUCTION THEREOF, USE OF THE SAME AND MICROORGANISMS THAT MANUFACTURE
Schlatter et al. The primary structure of the psychrophilic lactate dehydrogenase from Bacillus psychrosaccharolyticus
EP2281892A3 (en) Methods for producing polypeptides in respiratory-deficient Trichoderma cells
US4935351A (en) Process for preparing oligopeptide
WO2002010384A1 (en) Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin
AU6659896A (en) Protein with plant protecting properties
Tobe et al. Purification and some properties of alkaline proteinase from Bacillus sp.
DE69941789D1 (en) IN VIVO PROCEDURES FOR THE PREPARATION OF PROTEINS CONTAINING NON-CONVENTIONAL AMINO ACIDS
WO2001047958A3 (en) Kunitz domain polypeptide zkun10

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed